Publication Name	World Journal of Dermatology
Manuscript ID	29650
Country	Spain

Received	2016-08-24 10:13
Peer-Review Started	2016-08-24 21:36
To Make the First Decision	2016-09-27 17:15
Return for Revision	2016-10-08 11:14
Revised	2016-11-16 17:36
Second Decision	2017-01-10 16:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-01-22 15:04
Articles in Press	2017-01-22 15:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-04-20 16:57
Publish the Manuscript Online	2017-04-25 10:21

ISSN	2218-6190 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Retrospective Study
Article Title	Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve
Manuscript Source	Invited Manuscript
All Author List	Ricardo Palao, Jorge Aguilera-Sáez, Jordi Serracanta, Jose Manuel Collado, Bruce Patrik Dos Santos and Juan Pedro Barret
Funding Agency and Grant Number
Corresponding Author	Ricardo Palao, MD, Staff Member, Plastic, Reconstructive and Burns Unit Service, Vall d’Hebron University Hospital, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain. rpalao@vhebron.net
Key Words	Burns; Eschar; Debridement; Enzymatic debride¬ment; Wound bed; Nexobrid®; Epithelialization; Dermis preservation; Autograft
Core Tip	Burns continue to be a common injury in western countries. It is difficult to assess the severity of burns, but knowing its mechanisms as well as its characteristics can be of help. An alternative to surgical debridement is the enzymatic or chemical debridement, although past reports that used it with patients show that its efficiency is limited. Nexobrid® is a new enzymatic debridement agent. We show our learning curve with it.
Publish Date	2017-04-25 10:21
Citation	Palao R, Aguilera-Sáez J, Serracanta J, Collado JM, Dos Santos BP, Barret JP. Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve. World J Dermatol 2017; 6(2): 32-41
URL	http://www.wjgnet.com/2218-6190/full/v6/i2/32.htm
DOI	http://dx.doi.org/10.5314/wjd.v6.i2.32

Full Article (PDF)	WJD-6-32.pdf
Full Article (Word)	WJD-6-32.doc
Manuscript File	29650-Review.doc
Answering Reviewers	29650-Answering reviewers.pdf
Audio Core Tip	29650-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	29650-Conflict-of-interest statement.pdf
Copyright License Agreement	29650-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	29650-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	29650-Language certificate.pdf
Peer-review Report	29650-Peer-review(s).pdf
Scientific Misconduct Check	29650-Scientific misconduct check.pdf
Scientific Editor Work List	29650-Scientific editor work list.pdf